Evaluation of In vivo Bioactivity of a Mutated Streptokinase
<br /><p> </p><h2>Background: Immunogenicity of Streptokinase, as a thrombolytic drug, has limited its clinical use. Elimination of the amino acid residues that are responsible for immunogenicity while don’t affect the bioactivity of streptokinase is worthy. Recently, we modi...
Main Authors: | Marzieh Sameni, Mazaher Gholipourmalekabadi, Mojgan Bandehpour, Mehrdad Hashemi, Farzin Sahebjam, V Tohidi, Bahram Kazemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Shahid Beheshti University of Medical Sciences
2017-04-01
|
Series: | Novelty in Biomedicine |
Subjects: | |
Online Access: | http://journals.sbmu.ac.ir/nbm/article/view/13694 |
Similar Items
-
Contribution of Streptokinase-Domains from Groups G and A (SK2a) Streptococci in Amidolytic/Proteolytic Activities and Fibrin-Dependent Plasminogen Activation: A Domain-Exchange Study
by: Maryam Rafipour, et al.
Published: (2020-01-01) -
Evaluation of thrombolytic potential of three medicinal plants available in Bangladesh, as a potent source of thrombolytic compounds
by: Md. Ali, et al.
Published: (2014-11-01) -
Fibrinolytic Activity of Recombinant Mutant Streptokinase
by: Mahboobeh Mobarrez, et al.
Published: (2015-04-01) -
The comparison of streptokinase, an old agent, versus reteplase for the re-tunnellisation of blocked cuffed haemodialysis catheter
by: Saroukhani Abbas, et al.
Published: (2024-01-01) -
Efficacy of Two Streptokinase Formulations in Acute Myocardial Infarction: A Double-Blind Randomized Clinical Trial
by: Mojtaba Salarifar, et al.
Published: (2009-01-01)